SourceNet (SNET) Exploration Project Worth Billions


Subject: SourceNet (SNET) Exploration Project Worth Billions

View this email online if it doesn’t display correctly
SourcingLink.net
(SNET)

Exploration Project on Eldor Rare Earth Property

Estimated to be Worth Billions

SourcingLink.net is a exploration and development company with a focus on rare metals and rare earth elements, which are among the primary input materials of technology in the 21st century.

The Company is currently focused on exploration and development of its Eldor project in Quebec, Canada, which is recognized as one of the most favorable mining jurisdictions in the world.

Rare earth elements are vital materials utilized in many 21st Century Technologies, including in most sustainable energy technologies and a wide spectrum of defense applications.
China currently supplies 95% of the earth’s rare elementsthe ELDOR Project could be a Game Changer
Rare Earth Metals
Rare Earth Elements are a group of seventeen chemically similar metals.

The seven critical rare earth elements, neodymium (most important because neodymium is used in permanent magnets), europium, terbium, scandium, dysprosium, yttrium and the lanthanide elements.

Rare earths are an indispensable input to high-technology applications, including electric and hybrid vehicles, battery technology, wind turbines, cell phones, tablets, high definition televisions as well as other consumer electronics.
The Eldor Rare Earth Project is located in Quebec, Canada directly adjoins the west boundary of Commerce Resources Ashram Project which currently has a Assessment of $2.32 billion
SourcingLink.net Conducts Exploration Program on the Eldor Project, Quebec, Canada

SAN DIEGO, CA–(Marketwired – Nov 24, 2014)

SourcingLink.net, Inc. (PINKSHEETS: SNET) has completed a reconnaissance exploration program on the Eldor Rare Earth Property Claims (Eldor Project). The geological exploration program included an initial examination of the property for rare earth mineralization.
The purpose of the exploration project was threefold:
1) To investigate the high Rare Earth and Rare Earth indicator values in lake sediments on the property, which were previously surveyed by the Quebec Government.
2) To look for similar Rare Earth mineralization found by Commerce Resources. Commerce Resources has a property to the east and contiguous with the Eldor property of SNET. The neighboring property, Ashram project, currently has a PEA with a NPV at a 10% discount rate of $2.32 billion.
3) To investigate any other mineralization on the property that may be of economic interest.
Samples were collected and submitted for analysis. The analyses were performed at AGAT Labs, Toronto, Ontario, Canada using 4 Acid Digest – Metals Package, ICP-OES finish (201-070).
Significant values were reported and have been resubmitted for a complete rare earth analysis. Results from this testing will be available in the next coming weeks.
About The Eldor Project:
SourcingLink.net, Inc. signed an agreement to acquire 100% interest in the Eldor Rare Earth Property Claims (The Eldor Project) located in Northern Quebec, Canada. The Eldor Project consists of 32 mineral claims covering approximately 3719 acres and is located in Northern Quebec which is considered one of the most favorable mining jurisdictions in the world.
SourcingLink.net, Inc.
signed an agreement to acquire 100% interest in the Eldor Project located in Northern Quebec, Canada.

The Eldor Project consists of 21 mineral rights claims covering approximately 2438 acres

Projects
The Eldor Rare Earth Project is located in Quebec, Canada directly adjoins the west boundary of Commerce Resources Ashram Project which currently has a Assessment of 2.32 billion

The rare earth elements at Ashram occur in simple and well-understood mineralogy, being primarily in the mineral monazite and to a lesser extent in bastnaesite and xenotime. These minerals dominate the currently known commercial extraction processes for rare earths. The deposit has combination of Light ,Middle and Heavy Rare Earth Oxide (MHREO).

Sourcinglinknet.com intends to commence an initial work program in order to identity initial exploration drill targets. To date there have been significant indicators
SourcingLink.net
is a publicly traded exploration and development company with a focus on rare metals and elements which are among the primary input materials of technology in the 21st Century.
About the Ashram Rare Earth Element Deposit
The Ashram Rare Earth Element (REE) Deposit is a carbonatite within the Eldor Property, located in north-eastern Quebec.

The Deposit has a measured and indicated resource of 29.3 million tonnes at 1.90% TREO and an inferred resource of 219.8 million tonnes at 1.88% TREO. The deposit boasts a well-balanced distribution with enrichment in the light, middle and heavy rare earth elements including all five of the most critical elements (neodymium, europium, dysprosium, terbium, and yttrium).

The REEs at Ashram occur in simple and well-understood mineralogy, being primarily in the mineral monazite and to a lesser extent in bastnaesite and xenotime. These minerals dominate the currently known commercial extraction processes for rare earths.
A Preliminary Economic Assessment, completed in May of 2012 by SGS-Geostat of Montreal (Blainville) (see news release May 24, 2012), outlines robust economics for the Ashram Deposit. The PEA is based on a 4,000 tonne per day open-pit operation with an initial 25-year mine life (300 years at economic cut-off if open-pit + underground development), a pre-tax and pre-finance Net Present Value (NPV) of 2.32 billion at a 10% discount rate, a pre-tax/pre-finance Internal Rate of Return (IRR) of 44%, and a pre-tax/pre-finance payback period of 2.25 years.
The Ashram Rare Earth Element (REE) Deposit is a carbonatite within the Eldor Property, located in north-eastern Quebec.

The Deposit boasts a well-balanced distribution with enrichment rare earth elements including all five of the most critical elements (neodymium, europium, dysprosium, terbium, and
yttrium).

CMF indicator on the Stock Chart
is indicating investors are very Bullish on SNET.

SNET has had swings of 300% and we are now in the bottom of the zone.
SourcingLink.net
(SNET)

Visit Sourcinglink.net on the web at:
http://www.sourcinglink.org/

To Subscribe to our newsletter:StockPumper.com
Please read our disclaimer at: http://stockpumper.com/review-disclaimer.php

Disclaimer – Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment adviser or licensed stockbroker before investing. You should not invest or trade in any penny stock unless are you are fully prepared, willing, able and expect to lose a hundred pct of your funds,including any profiled company or other company in any other manner mentioned or alluded to by StockPumper.com as defined in any medium whatsoever. Compensation: One thousand dollars for a one day awareness on SNET from a third party.The service is provided as a guide to some available investments only, which must be tempered by the investment experience and independent decision making process of the subscriber. The accuracy of issuer documents and information that is submitted to and, its affiliated members and its management for inclusion on this site is principally the responsibility of the particular issuer and its management, its affiliated members and its management is neither responsible for, nor undertakes any steps to check, the accuracy of any information provided by featured companies to potential investors. You should confirm to your own satisfaction the veracity of any information prior to entering into any investment.

SourcingLink.net (SNET) Conducts Exploration Program on the Eldor Project, Quebec, Canada


SourcingLink.net (SNET) Conducts Exploration Program on the Eldor Project, Quebec, Canada

SAN DIEGO, CA–(Marketwired – Nov 24, 2014) – SourcingLink.net, Inc. (PINKSHEETS: SNET) has completed a reconnaissance exploration program on the Eldor Rare Earth Property Claims (Eldor Project). The geological exploration program included an initial examination of the property for rare earth mineralization.

The purpose of the exploration project was threefold: 

1) To investigate the high Rare Earth and Rare Earth indicator values in lake sediments on the property, which were previously surveyed by the Quebec Government.

2) To look for similar Rare Earth mineralization found by Commerce Resources. Commerce Resources has a property to the east and contiguous with the Eldor property of SNET. The neighboring property, Ashram project, currently has a PEA with a NPV at a 10% discount rate of $2.32 billion.

3) To investigate any other mineralization on the property that may be of economic interest.
Samples were collected and submitted for analysis. The analyses were performed at AGAT Labs, Toronto, Ontario, Canada using 4 Acid Digest – Metals Package, ICP-OES finish (201-070).
Significant values were reported and have been resubmitted for a complete rare earth analysis. Results from this testing will be available in the next coming weeks.

About The Eldor Project: 

SourcingLink.net, Inc. signed an agreement to acquire 100% interest in the Eldor Rare Earth Property Claims (The Eldor Project) located in Northern Quebec, Canada. The Eldor Project consists of 32 mineral claims covering approximately 3719 acres and is located in Northern Quebec which is considered one of the most favorable mining jurisdictions in the world.

About SourcingLink.net, Inc.:

SourcingLink.net is a U.S. based publicly traded exploration and development company with a focus on rare metals and rare earth elements which are among the primary input materials of technology in the 21st Century.

NXT-ID Short Interest Down 35.0% in October (NXTD)


NXT-ID Short Interest Down 35.0% in October (NXTD)

 http://www.wkrb13.com

NXT-ID (NASDAQ:NXTD) was the target of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 408,456 shares, a decrease of 35.0% from the October 15th total of 628,091 shares, Analyst Ratings.Net reports. Based on an average trading volume of 272,371 shares, the short-interest ratio is presently 1.5 days. Currently, 6.5% of the shares of the company are short sold.

Several analysts have recently commented on the stock. Analysts at Benchmark Co. initiated coverage on shares of NXT-ID in a research note on Thursday, October 9th. They set a “buy” rating and a $6.00 price target on the stock. Analysts at Northland Securities initiated coverage on shares of NXT-ID in a research note on Tuesday, September 30th. They set an “outperform” rating and a $6.00 price target on the stock.

NXT-ID (NASDAQ:NXTD) opened at 2.31 on Monday. NXT-ID has a 52-week low of $1.36 and a 52-week high of $5.90. The stock’s 50-day moving average is $2.63 and its 200-day moving average is $3.42. The company’s market cap is $55.8 million.

SourcingLink.net Inc. Conducts Reconnaissance Exploration Program at Eldor Property in Northern Quebec


SourcingLink.net Inc. Conducts Reconnaissance Exploration Program at Eldor Property in Northern Quebec


http://finance.yahoo.com/

SAN DIEGO, CA–(Marketwired – Nov 5, 2014)
SourcingLink.net Inc. (PINKSHEETS: SNET) has recently completed an initial reconnaissance and exploration program at its Eldor Property in northern Quebec for which SourcingLink owns 100% of the mining claims.
The purpose of the property investigation was as follows:
1) To investigate the high rare earth and rare earth indicator values in lake sediments on the property.

2) To look for similar rare earth mineralization found by Commerce Resources on the contiguous property to the East.
3) To investigate other mineralization on the property that may be of economic interest.
4) The target area on the SNET property was a small lake where anomalous high values of rare earths were detected in a government lake sediment survey. 
The SNET program was conducted in late October by a crew of two, geologist Wayne Holmstead and a helicopter pilot from Heli-Explore of La Sarre, Quebec. The executed plan included walking GPS traverses in the area of interest and using instruments such as a scintillometer, X-Ray Flourescence Analyzer and an electromagnetic detector in order to outline areas of interest. Collected samples were sent to AGAT Labs in Toronto, Ontario, Canada for multi-element ICP analysis. Results are expected within the next 30 days.

The Eldor Project located in Northern Quebec, Canada adjoins the west boundary of Commerce Resources’ Ashram Project. The neighboring property, Ashram project, currently has a Preliminary Economic Assessment (PEA) with a Net Present Value (NPV) at a 10% discount rate of $2.32 billion, (a pre-tax/pre-finance Internal Rate of Return (IRR) of 44%).

About The Eldor Project:

SourcingLink.net, Inc. signed an agreement to acquire 100% interest in the Eldor Rare Earth Property Claims (The Eldor Project) located in Northern Quebec, Canada. The Eldor Project consists of 21 mineral claims covering approximately 2438 acres and is located in Northern Quebec which is considered one of the most favorable mining jurisdictions in the world.

About SourcingLink.net, Inc.:

SourcingLink.net is a U.S. based publicly traded exploration and development company with a focus on rare metals and rare earth elements which are among the primary input materials of technology in the 21st Century.

NXT-ID to Close Pre-Orders for Wocket(TM) Smart Wallet; First Wockets to Ship in 2014


NXT-ID to Close Pre-Orders for Wocket(TM) Smart Wallet; First Wockets to Ship in 2014

General Release to Follow 2015 International CES (Consumer Electronics Show)

SHELTON, CT–(Marketwired – Nov 10, 2014) – NXT-ID, Inc. (NASDAQ: NXTD) (NASDAQ: NXTDW) (“NXT-ID” or the “Company”), a biometric authentication company focused on the growing mobile commerce market announces it will close pre-orders at midnight on November 14, 2014 in the lead up to its launch of the Wocket™ smart wallet.

Gino Pereira, CEO of NXT-ID, said, “We would like to thank all of our loyal customers for their pre-orders. It was a significant vote of confidence in our product to pay full price in a pre-order phase. We will officially close pre-sale orders of the Wocket Smart Wallet this Friday to prepare for upcoming shipments. Customers who have secured their order will be part of an exclusive group to receive the very first Wockets in the world. We anticipate shipping the first units prior to the end of the year. General release of Wocket to non-pre-order customers will begin following CES in January 2015.”

After Friday, new customers are encouraged to request an invitation via the website at www.wocketwallet.com to be one of the first to get their hands on the revolutionary Wocket in the upcoming general release. There is no cost to make the request and invitations will be issued on a first come first served basis to be next in line to purchase and receive their wockets in advance of our general release to the public.
NXT-ID will be exhibiting the Wocket at the upcoming 2015 International CES (Consumer Electronics Show), the world’s gathering place for all who thrive on the business of consumer technologies, in Las Vegas, January 6-9, 2015. The Company will be located at booths 21926 and 21927 in the South Hall lower level. Additionally the Company will be hosting a press conference at CES, the timing of which will be announced at a later date.
Wocket™ is a smart wallet, the next evolution in smart devices, following the smart phone and smart watch. Wocket™ is a next generation smart wallet designed to protect your identity and replace all the cards in your wallet, with no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.
Credit, debit, ATM, loyalty, gift, ID, membership, insurance, ticket, emergency, medical, business, contacts, coupon, and virtually any card can be protected on Wocket™. More than 10,000 cards, records, coupons, etc. can also be stored on Wocket™.
 About NXT- ID Inc. – Mobile Security for a Mobile World: (NXTD) (NXTDW):
NXT-ID, Inc.’s innovative MobileBio® solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio® suite of biometric solutions that secure consumers’ mobile platforms led by the Wocket™ ; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.
NXT-ID’ wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/

Court ruling favors GenSpera in U.S. patent dispute


Court ruling favors GenSpera in U.S. patent dispute

By Peggy O’Hare
http://www.mysanantonio.com/ 
http://stockpumpers.blogspot.com/2014/11/court-ruling-favors-genspera-in-us.html
 SAN ANTONIO — A San Antonio company developing prodrug therapeutics to treat cancer said Thursday that a federal court ruled in its favor in a patent dispute.

GenSpera Inc. said it welcomed the Sept. 12 decision by a U.S. District Court in Maryland, which essentially dismisses Dr. Annastasiah Mhaka’s claims that she was wrongly omitted from two of the company’s U.S. patents for its lead drug candidate, mipsagargin.

Mhaka had worked as a post-graduate student for two of GenSpera’s founders who obtained the patents, Johns Hopkins University professors Samuel Denmeade and John Isaacs. Mhaka claimed she should have been credited as a co-inventor of the pharmaceutical. The company denied that.
“Our defense against these claims has demonstrated GenSpera’s commitment to protecting its technologies and intellectual property portfolio,” CEO Craig Dionne said.

About GenSpera
GenSpera’s technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that provides for the targeted release of drug candidates within a tumor. Unlike typical chemotherapeutic agents, thapsigargin results in cell death irrespective of the rate of cell division, which may provide an effective approach to kill both fast- and slow-growing cancers. GenSpera’s lead drug candidate, mipsagargin, is activated by the enzyme PSMA, which is found at high levels in the vasculature of liver and glioblastoma cancers and in the vasculature of almost all other solid tumors. Mipsagargin is expected to have potential efficacy in a wide variety of tumor types.

Tamino Minerals, Inc.’s Geologist Targeting 5 Rich New Properties Along With The Engagement Of A New Financial Advisor


Tamino Minerals, Inc.’s Geologist Targeting 5 Rich New Properties Along With The Engagement Of A New Financial Advisor

 Tamino Minerals, Inc. (OTC MARKETS: TINO), a Junior Exploration Mining Company that explores for precious minerals and other metals in the country of Mexico, announced today the targeting of 5 new exciting properties by its geologist and the engagement of a financial advisor to assist the company with identifying and evaluating strategic growth options to maximize value for the company’s stakeholders.

Pedro Villagran-Garcia, President and CEO of Tamino Minerals, Inc., said, “Our differentiated approach toward exploring for Mexico’s Natural Resources has made effect in the Market already. Our Board of Directors is undertaking this review to identify the best way to maximize the value of our assets for our stakeholders given our current financial position and market dynamics in the Mining Exploration Industry.”

The company´s financial position has vastly improved as we are making this transition. New shareholders have been an integral part of our growth and expansion. The company is still negotiating an ongoing financing with a very reputable institutional entity. We will soon make a much more detailed announcement on this matter.
The geologists are exploring properties across multiple states: Michoacán, Oaxaca, Zacatecas, Guerrero, Sinaloa and Sonora.

In particular, the focus is on: Copper and Silver Porphyries, epithermal Gold and Silver, Iron Ore and Baryte.

Silver demand continues to rise with supply lagging behind, pushing the price of Silver up over 200% in the past 10 years.

Mexico is the 10th largest Gold producer, with production approaching 100 tonnes per year, worth about $5 Billion annually.

Internationally, the market for Copper is one of the largest of all metals behind iron and aluminum, over $150 billion annually, with China’s demand a whopping 43% (Source:ICSG and IMF). Porphyry ore-bodies (the largest source of copper ore) can be economic from copper concentrations as low as 0.4% copper.

For more information on this news release feel free to contact our President & CEO, Mr. Pedro Villagrán-García, Professional Engineer and Master in Business Administration.

GenSpera Announces Completion of Patient Enrollment in the Phase II Clinical Trial of Mipsagargin in Liver Cancer Patients


GenSpera Announces Completion of Patient Enrollment in the Phase II Clinical Trial of Mipsagargin in Liver Cancer Patients 

http://www.pipelinereview.com

 SAN ANTONIO, TX, USA I GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, today announced that patient enrollment has been completed in the company’s Phase II clinical trial in patients with liver cancer (hepatocellular carcinoma). Formal results of the study are expected to be available during the first quarter of 2015.

“We are grateful to the trial investigators for their efforts, as well as the patients and their loved ones who are supporting this important trial,” said Craig Dionne, PhD, GenSpera’s CEO. “The completion of the enrollment period for this trial marks another company milestone. The data we have collected to date establish proof of concept for mipsagargin’s destruction of blood vessels within tumors and encouraging signs of potential anti-tumor activity. We anticipate similar results in our ongoing Phase II trials in patients with glioblastoma as well as our planned Phase II trial in patients with prostate cancer.”

Interim data from the ongoing Phase II clinical trial in liver cancer patients were recently presented at the Asia Pacific Primary Liver Cancer Expert Meeting in Taipei in July 2014 (APPLE2014) and at the International Liver Cancer Association (ILCA) meeting in Kyoto in September 2014. Impressively, 80% of liver cancer patients in the Phase Ib and Phase II studies experienced disease stabilization at two months and a significant percentage of patients had stable disease for at least nine months after beginning treatment with mipsagargin.

The US Food and Drug Administration (FDA) granted Orphan Drug designation in 2013 for the evaluation of mipsagargin in patients with hepatocellular carcinoma.

About GenSpera 

GenSpera’s technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that provides for the targeted release of drug candidates within a tumor. Unlike typical chemotherapeutic agents, thapsigargin results in cell death irrespective of the rate of cell division, which may provide an effective approach to kill both fast- and slow-growing cancers. GenSpera’s lead drug candidate, mipsagargin, is activated by the enzyme PSMA, which is found at high levels in the vasculature of liver and glioblastoma cancers and in the vasculature of almost all other solid tumors. Mipsagargin is expected to have potential efficacy in a wide variety of tumor types.

Mipsagargin Phase II clinical trials are underway in both hepatocellular carcinoma (liver cancer) and glioblastoma patients (brain cancer).

AVEW Holdings Reports an Increase in Third Quarter Results and Robust Contract Pipeline


AVEW Holdings Reports an Increase in Third Quarter Results and Robust Contract Pipeline

http://finance.yahoo.com

AVEW Holdings Inc. (OTC: AVEW) today announced the company reported its third quarter financial status to OTC Markets. The financial condition of AVEW has improved by 335% in Balance Sheet Equity from $98,316 to $329,832 and a cash position from $(26) to $ 62,223 at the end of third quarter 2014 compared to December year-end 2013 financials. In addition, there has been a reduction of over $120,000 in debt since year-end 2013. Not shown in the financial statement is a significant new contract pipeline in new pools and outdoor living construction. Austin Premier Pools and Spas currently has $408,000 in contracts pending financing approval and $528,500 in additional contracts while Austin Patio & Outdoor Living has $350,000 in contracts pending financing and an additional $115,000 in new contracts.

Other noteworthy accomplishments have been the completion of three acquisitions; two major equipment dealerships; equipment partnership with Pentair Aquatic Systems; hired two new managers and a Director of Sales; four definitive agreements to acquire a pool company, a nursery/landscaping contractor, a fence and construction company and a custom home builder; formed four new divisions to accommodate and support custom builders, and executed two financing agreements with Capital Market Groups totaling 10 million dollars in committed financing.

Mr. Jose Chavez, CEO of AVEW, commented, “We have come a long way from the initial Action View International Inc business format and financial position. Our management team has done an outstanding job in executing AVEW’S New Business Model.” With the finalization of a few of the Definitive Agreements plus successful completion of work pipeline, AVEW stands to surpass the projected year end revenues of $5,000,000. Mr. Jay Ling President of AVEW stated “AVEW’S current business overview clearly demonstrates that AVEW is poised not only to be a profitable and successful business, but also will surpass the management projected revenues forecast for 2014, 2015, and beyond.”

About AVEW Holding s Inc. :
 

AVEW HOLDINGS is a full service pool, spa and landscape design and construction company. Austin Premier Pools & Spas is a custom pool design and construction company that has won national and regional pool construction and design awards. Fantastic Pool Services is a maintenance and pool repair company doing business in central Texas. Austin Patio & Outdoor Living is a new and residential remodel Construction Company servicing central Texas. Austin Patio also designs and installs landscaping and outdoor living kitchens, fireplaces, cabanas, and decks. Kustom Fence and Construction Company is a custom fence designer and builder serving the Hill Country.

GenSpera Announces Melanie Thomas, MD, MS, Will Serve Company As Medical Adviser


GenSpera Announces Melanie Thomas, MD, MS, Will Serve Company As Medical Adviser

SAN ANTONIO, Texas, October 16, 2014 /PRNewswire/

GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, today announced that Melanie Thomas, MD, MS, a recognized worldwide leader in the field of liver cancer, will join the company as Medical Adviser.

Dr. Thomas most recently held the Grace E. DeWolff Chair in Gastrointestinal Oncology at the Medical University of South Carolina and served as Associate Director of Clinical Investigations. As Associate Director, Dr. Thomas had primary responsibility to oversee all clinical research infrastructure at Hollings Cancer Center. Dr. Thomas has served as Principal Investigator on twenty-nine separate clinical trials, primarily in gastrointestinal cancers as well as held previous appointments at MD Anderson Cancer Center.

“Primary liver cancer (hepatocellular carcinoma) is a very challenging disease in which to develop new, novel therapeutic agents that are both effective and safe for patients,” said Dr. Thomas. “Hepatocellular carcinoma is a highly chemotherapy-resistant tumor, and most patients have underlying liver damage that limits their eligibility for clinical trials. As the third most common cancer worldwide, hepatocellular carcinoma remains a significant unmet medical need. The early data for mipsagargin safety and efficacy in liver cancer are impressive, and I am excited to be part of the team that is developing this novel agent for liver cancer patients.”

“We have always actively sought the best medical and scientific counsel in our ongoing mission to deliver innovative therapies to cancer patients,” said Craig Dionne, PhD, GenSpera’s CEO. “Dr. Thomas is a highly respected physician who brings a wealth of clinical experience to our team. We are delighted and honored that she has chosen to focus her efforts on the clinical development of mipsagargin.”

About GenSpera

GenSpera’s technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that provides for the targeted release of drug candidates within a tumor. Unlike typical chemotherapeutic agents, thapsigargin results in cell death irrespective of the rate of cell division, which may provide an effective approach to kill both fast- and slow-growing cancers. GenSpera’s lead drug candidate, mipsagargin, is activated by the enzyme PSMA, which is found at high levels in the vasculature of liver and glioblastoma cancers and in the vasculature of almost all other solid tumors. Mipsagargin is expected to have potential efficacy in a wide variety of tumor types.

The US Food and Drug Administration (FDA) granted Orphan Drug designation in 2013 for the evaluation of mipsagargin in patients with hepatocellular carcinoma. Mipsagargin Phase II clinical trials are underway in both hepatocellular carcinoma (liver cancer) and glioblastoma patients (brain cancer)

For more information, please visit the company’s website: 
www.genspera.com or follow us on Twitter @GenSperaNews.

Company presentations are available at: 
http://www.genspera.com/

Watch the Corporate Video:
http://youtu.be/jULjEul-mBk